Presented by Dr. Adam J. Prus, this one-hour long webinar offered an overview of the monoamine hypothesis of antidepressant drug actions. Participants learned about general research and development approaches for developing novel antidepressant drugs. The presentation focused on a new class of antidepressant drugs called Triple Reuptake Inhibitors, which are currently being tested in clinical trials.